Fosrenol data show evidence of trends towards improved bone formation in CKD stage 5 patients

Treatment with the phosphate binder FOSRENOL(R) (lanthanum carbonate) was associated with slight improvements in bone formation in chronic kidney disease (CKD) Stage 5 patients with hyperphosphatemia (high phosphorus levels in the blood), according to long-term (two-year) data presented at the American Society of Nephrology (ASN) meeting. Additional studies presented at ASN document the efficacy and safety of the reformulated and higher-dose FOSRENOL tablets.

Heart Disease :: Tβ4 is essential for coronary vessel development report

REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) reported today that a study published in the advanced online edition of the journal Nature supported and elaborated TB4’s significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans.

Targeting leukemic stem cells by Bcl-2 inhibition

Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.

Does natural selection drive the evolution of cancer?

The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams. This is the view of researchers in an emerging cross-disciplinary field that brings the thinking of ecologists and evolutionary biologists to bear on cancer biology.

Heart Disease :: Adult heart cells learn to heal

Cells in the outermost layer of the heart can be guided by a specific protein to move deeper inside and help to repair a failing adult heart. Research published today by Nature, reveals how thymosin ?4, a protein already known for its ability to reduce muscle cell loss after heart attack, can instruct the heart to heal itself.

San Diego Medication Safety Task Force Creates Unique Collaboration

Local hospitals throughout San Diego County, along with San Diego Patient Safety Consortium and the Cardinal Health Center for Safety and Clinical Excellence, today announced the results of a first-of-its-kind regional task force to improve patient safety by eliminating variation in intravenous (IV) medication practices among county hospitals.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack